Skip to main content
Top

Journal of Cancer Survivorship

Issue 1/2023

Special issue on Ototoxicity

Content (22 Articles)

Review

Special considerations in the design and implementation of pediatric otoprotection trials

David R. Freyer, Etan Orgel, Kristin Knight, Mark Krailo

Prevalence and risk factors for ototoxicity after cisplatin-based chemotherapy

Victoria A. Sanchez, Paul C. Dinh Jr., Jennessa Rooker, Patrick O. Monahan, Sandra K. Althouse, Chunkit Fung, Howard D. Sesso, Lawrence H. Einhorn, M. Eileen Dolan, Robert D. Frisina, Lois B. Travis

Associations among hearing loss, multiple co-occurring symptoms, and quality of life outcomes in cancer survivors

Christine Miaskowski, Judy Mastick, Steven Paul, Margaret Wallhagen, Gary Abrams, Jon D. Levine

Open Access Tinnitus

Audiologists’ perceived value of ototoxicity management and barriers to implementation for at-risk cancer patients in VA: the OtoMIC survey

Dawn Konrad-Martin, Rachel Polaski, J. Riley DeBacker, Sarah M. Theodoroff, Angela Garinis, Cecilia Lacey, Kirsten Johansson, Rosemarie Mannino, Trisha Milnes, Michelle Hungerford, Khaya D. Clark

Ototoxicity prognostic models in adult and pediatric cancer patients: a rapid review

J. R. DeBacker, G. P. McMillan, N. Martchenke, C. M. Lacey, H. R. Stuehm, M. E. Hungerford, D. Konrad-Martin

Open Access Amenorrhoea

Quality of life among female childhood cancer survivors with and without premature ovarian insufficiency

Hjelmér Ida, Gustafsson Kylberg Alicia, Fridenborg Anna, Leijonhufvud Irene, Nyström Anna, Mörse Helena, Elfving Maria, Henic Emir, Nenonen Hannah

Open Access Lymphoma

Self-reported causes of cancer among 6881 survivors with 6 tumour types: results from the PROFILES registry

Carla Vlooswijk, Olga Husson, Simone Oerlemans, Nicole Ezendam, Dounya Schoormans, Belle de Rooij, Floortje Mols

Feasibility and acceptability of home-based strength training in endometrial cancer survivors

Jessica Gorzelitz, Erin Costanzo, Ronald Gangnon, Kelli Koltyn, Amy Trentham Dietz, Ryan J Spencer, Joanne Rash, Lisa Cadmus-Bertram

A prospective study of lifestyle factors and bone health in breast cancer patients who received aromatase inhibitors in an integrated healthcare setting

Marilyn L. Kwan, Joan C. Lo, Cecile A. Laurent, Janise M. Roh, Li Tang, Christine B. Ambrosone, Lawrence H. Kushi, Charles P. Quesenberry Jr, Song Yao

Open Access Breast Cancer

Pain sensitivity and shoulder function among breast cancer survivors compared to matched controls: a case-control study

G. H. F. Rasmussen, P. Madeleine, M. Arroyo-Morales, M. Voigt, M. Kristiansen

The financial impact of cancer on Canadian young adults

Kaitlyn N. Mahon, Sheila N. Garland, Geoff Eaton, Karine Chalifour, Breanna E. Lane, Ken Fowler, Lynn Gambin, Luc Clair

Care Review

Effectiveness and implementation of models of cancer survivorship care: an overview of systematic reviews

Raymond J. Chan, Fiona Crawford-Williams, Megan Crichton, Ria Joseph, Nicolas H. Hart, Kristi Milley, Paige Druce, Jianrong Zhang, Michael Jefford, Karolina Lisy, Jon Emery, Larissa Nekhlyudov

Obesity Review

Metabolic and lifestyle risk factors for chemotherapy-induced peripheral neuropathy in taxane and platinum-treated patients: a systematic review

Hannah C. Timmins, David Mizrahi, Tiffany Li, Matthew C. Kiernan, David Goldstein, Susanna B. Park

Age as a risk factor for breast cancer-related lymphedema: a systematic review

Gunel Guliyeva, Maria T. Huayllani, Daniel Boczar, Francisco R. Avila, Xiaona Lu, Antonio Jorge Forte

Webinar | 19-02-2024 | 17:30 (CET)

Keynote webinar | Spotlight on antibody–drug conjugates in cancer

Antibody–drug conjugates (ADCs) are novel agents that have shown promise across multiple tumor types. Explore the current landscape of ADCs in breast and lung cancer with our experts, and gain insights into the mechanism of action, key clinical trials data, existing challenges, and future directions.

Dr. Véronique Diéras
Prof. Fabrice Barlesi
Developed by: Springer Medicine